Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kamil Ali-jackson

Director at Rigel Pharmaceuticals Inc (RIGL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $160K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 24SEC RIGLRigel Pharmaceuticals Inc Sell Plan 2,50010,125 held (−20%) $35.00 $88K +31.3%
May 28SEC RIGLRigel Pharmaceuticals Inc Sell Plan 2,50012,625 held (−17%) $29.17 $73K +57.6%
  • Sell

    Director Kamil Ali-jackson sold $88K of RIGL at $35.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kamil Ali-jackson sold $73K of RIGL at $29.17 — pre-scheduled 10b5-1 plan sale.